glp 1 drugs comparison New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks Free Energy GLP-1 Receptor Agonists | New
Description
Conclusions GLP-1 agonists have become a cornerstone of cardiovascular medicine by showing substantial reductions in MACE and heart failure events and stroke, along with potential benefits for vascular dementia
Gonzalez A, Hall MN, Lin SC, Hardie DG
FAQs Could anti-obesity drugs eventually replace bariatric surgery
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial
